Organization
University of Pennsylvania, Philadelphia, PA
5 abstracts
1 poster
Abstract
Correlation of HER2 low status in I-SPY2 with molecular subtype, response, and survival.Org: University of California Comprehensive Cancer Center, San Francisco, CA, University of California, San Francisco, San Francisco, CA, University of Texas MD Anderson Cancer Center, Houston, TX, UC Davis, Davis, CA, Masonic Cancer Center, Minneapolis, MN,
Abstract
A randomized, double-blind, placebo-controlled phase II study of adjuvant pembrolizumab versus placebo in patients with head and neck squamous cell cancers at high risk for recurrence: The PATHWay study.Org: Department of Medicine, University of Chicago, Johns Hopkins Medicine, University of Pennsylvania, Emory University Winship Cancer Institute, Hollings Cancer Center,
Abstract
Rates of pathologic complete response (pCR)after neoadjuvant datopotamab deruxtecan (Dato): Results from the I-SPY2.2 trial.Org: Winship Cancer Institute of Emory University, Atlanta, GA, University of Alabama at Birmingham, Birmingham, AL, University of California, San Francisco, San Francisco, CA, University of California, San Diego, La Jolla, CA, UC Davis Comprehensive Cancer Center, Sacramento, CA,
Abstract
Streamlining regulatory review in a multicenter platform trial: Opportunity to enhance patient centered care and drive innovation and efficiency.Org: University of California, San Francisco, San Francisco, CA, University of California San Diego Ideker Laboratory, La Jolla, CA, Wake Forest, Winston-Salem, NC, University of California Berkeley, School of Public Health, Berkeley, CA, Alliance for Cancer Clinical Trials, Dana Farber Cancer Institute, I-SPY2, Wrentham, MA,
Abstract
Patterns of failure in metastatic non-small cell lung cancer (mNSCLC) treated with first line pembrolizumab and use of local therapy in patients with oligoprogression.Org: Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, University of Pennsylvania, Philadelphia, PA, Division of of Pulmonary Medicine, Abraham Cancer Center, University of Pennsylvania, Philadelphia, PA, Department of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA,